UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
A new AI tool developed by UC San Diego researchers uses clinical data to predict colorectal cancer risk in ulcerative colitis patients, helping clinicians make evidence‑based care decisions and preventing treatment delays.
Meet UC San Diego Skaggs School of Pharmacy alum Courtney Shakowski, PharmD ’11, who now works at Novo Nordisk as a medical liaison where she helps transform today’s research into tomorrow’s treatments.
UC San Diego study reveals that toxin‑related chronic rhinosinusitis shows a two‑fold rise in sinus mast cells, pointing to a new therapeutic target for veterans and others exposed to smoke airway risk factor.
UC San Diego researchers have harnessed the body's immune response to a common virus to shrink pancreatic tumors, offering hope for a new cancer treatment approach.
At the 2026 Indigi-Con Creators Symposium, the Indigenous Futures Institute will bring artists and advocates together to celebrate Indigenous culture, storytelling and creativity, and uplifting Indigenous knowledge through community-based programming for the next generation.
By mapping the varied states of our body's immune cells, UC San Diego researchers are working to empower the next generation of cancer immunotherapies.
Washington Post, November 9
New York Times, September 23
Forbes, September 8
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
